Compare GEVO & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GEVO | ABSI |
|---|---|---|
| Founded | 2005 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 453.1M | 418.0M |
| IPO Year | 2010 | 2021 |
| Metric | GEVO | ABSI |
|---|---|---|
| Price | $1.91 | $2.84 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 6 |
| Target Price | $6.42 | ★ $7.98 |
| AVG Volume (30 Days) | 2.0M | ★ 2.6M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 21.67 |
| EPS | ★ N/A | N/A |
| Revenue | $711,000.00 | ★ $4,534,000.00 |
| Revenue This Year | $913.54 | $10.72 |
| Revenue Next Year | $9.75 | $313.07 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.92 | $2.01 |
| 52 Week High | $2.95 | $5.23 |
| Indicator | GEVO | ABSI |
|---|---|---|
| Relative Strength Index (RSI) | 50.84 | 50.35 |
| Support Level | $1.56 | $2.49 |
| Resistance Level | $2.14 | $2.89 |
| Average True Range (ATR) | 0.08 | 0.18 |
| MACD | 0.01 | 0.04 |
| Stochastic Oscillator | 88.24 | 95.65 |
Gevo Inc is a next-generation diversified energy company committed to fueling America's future with cost-effective, drop-in fuels that contribute to energy security, abate carbon, and strengthen rural communities to drive economic growth. Its technology can be used to make a variety of renewable products, including sustainable aviation fuel (SAF), motor fuels, chemicals, and other materials that provide U.S.-made solutions. The business model includes developing, financing, and operating production facilities that create jobs and revitalize communities. It owns and operates an ethanol plant with an adjacent CCS facility, Class VI carbon-storage well, and others. The group is currently developing the world's first large-scale ATJ facility to be co-located at the North Dakota site.
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.